News Focus
News Focus
Post# of 257437
Next 10
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 191684

Thursday, 06/04/2015 11:45:51 AM

Thursday, June 04, 2015 11:45:51 AM

Post# of 257437
ABBV-JNJ—Imbruvica shows statsig PFS/OS in phase-3 trial in first-line CLL/SLL:

http://finance.yahoo.com/news/ibrutinib-imbruvica-improved-survival-treatment-132000678.html

The trial design was Imbruvica head-to-head vs chemotherapy.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up